Search Results 8601-8610 of 34300 for oral
Subjects who have received a live/attenuated vaccine within 30 days of randomization (e.g., varicella, zoster, yellow fever, rotavirus, oral polio and measles, ...
... oral="" dose)="" or="" titrated="" estradiol="" dosing="" to="" achieve="" average="" premenopausal="" estradiol="" level="" (80-120="" pg/ml),="" to ...
r, Oral and throat cancer, Mouth cancer, Thyroid cancer, Head and neck cancer, Salivary gland tumor, Soft palate cancer, Nasal and paranasal tumors ...
vascular surgery, Parotidectomy, Transoral laser microsurgery, Throat cancer, Oral and throat cancer, Mouth cancer, Thyroid cancer, Head and neck cancer ...
Patient who is not on oral anticoagulation therapy for at least 3 weeks prior to the ablation procedure 6. Presence of a permanent pacemaker, biventricular ...
The study will also determine the influence of chemoprevention therapies such as tamoxifen and letrozole on qLI. Oral Tamoxifen vs. TamGel vs. Control in ...
Artifacts and Safety of Oral Metals in Subjects Undergoing High-field Strength Brain Magnetic Resonance Imaging (P12-2.007). Neurology. 2025 Apr 8; 104 ...
Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Sleep Medicine in Minnesota · Sleep Medicine · Sleep Surgery Clinic ...
This phase II trial studies how well giving ruxolitinib phosphate (oral JAK inhibitor INCB18424) works in treating patients with relapsed or refractory diffuse ...
People with Friedreich ataxia can be treated with an oral medicine called omaveloxolone (Skyclarys). The U.S. Food and Drug Association approved the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.